Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lung Neoplasms × Iloprost × Clear all

Phase

Phase 2 2 Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Radiotherapy 33 pembrolizumab 32 Cisplatin 32 Carboplatin 31 Pemetrexed 23 Paclitaxel 22 Docetaxel 17 Specimen Handling 16 Magnetic Resonance Spectroscopy 16 Gemcitabine 16 Nivolumab 15 Cyclophosphamide 14 osimertinib 13 Bevacizumab 13 Irinotecan 12 Etoposide 12 Erlotinib Hydrochloride 12 durvalumab 11 Radiation 11 Cetuximab 9 Topotecan 8 Immunoglobulin G 8 Disulfides 8 Celecoxib 8 fludarabine 7 Radiosurgery 7 Fluorouracil 7 Everolimus 7 Biopsy 7 atezolizumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02237183 2023-11-28

Iloprost in Preventing Lung Cancer in Former Smokers

National Cancer Institute (NCI)

Phase 1 Completed

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡